BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15719617)

  • 1. IL-10 and IL-12p40 in Egyptian patients with HCV-related chronic liver disease.
    Hassoba H; Leheta O; Sayed A; Fahmy H; Fathy A; Abbas F; Attia F; Serwah A
    Egypt J Immunol; 2003; 10(1):1-8. PubMed ID: 15719617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Th1/Th2 imbalance in HCV-related liver cirrhosis].
    Sakaguchi E; Kayano K; Segawa M; Aoyagi M; Sakaida I; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1259-63. PubMed ID: 11494534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IL-12 B Gene Polymorphism with Staging of Liver Disease in Chronic HCV Patients.
    Elwan N; Amr K; Elyamany S; Elkhalawany W; Soliman S; Ziada M; Abd-Elsalam S
    Infect Disord Drug Targets; 2018; 18(2):122-128. PubMed ID: 28595541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection.
    Kakumu S; Ito S; Ishikawa T; Mita Y; Tagaya T; Fukuzawa Y; Yoshioka K
    J Gastroenterol Hepatol; 2000 Apr; 15(4):431-6. PubMed ID: 10824889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection.
    Abayli B; Canataroğlu A; Akkiz H
    Turk J Gastroenterol; 2003 Mar; 14(1):7-11. PubMed ID: 14593531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.
    El-Kady IM; Lotfy M; Badra G; El-Masry S; Waked I
    Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
    Suneetha PV; Goyal A; Hissar SS; Sarin SK
    J Med Virol; 2006 Aug; 78(8):1055-60. PubMed ID: 16789008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TH1/TH2 serum cytokine profiles and soluble TNF-receptor response in patients with chronic hepatitis C during recombinant human interleukin-12 (rHuIL-12) treatment.
    Teuber G; Rossol S; Lee JH; Dietrich CF; Zeuzem S
    Z Gastroenterol; 2002 Jul; 40(7):487-95. PubMed ID: 12122596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Cytokine of IL-10 and IL-12 in Chronic Liver Disease: The Immune and Inflammatory Response.
    El-Emshaty HM; Nasif WA; Mohamed IE
    Dis Markers; 2015; 2015():707254. PubMed ID: 26783377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection.
    Emam EA; Emam M; Shehata AE; Emara M
    Egypt J Immunol; 2006; 13(2):33-40. PubMed ID: 18689269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients.
    Lapiński TW
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):311-6. PubMed ID: 11726034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.